Molecular pathology of allergic disease - II: Upper airway disease

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 2 II, 2000, Pages 211-223

  Christodoulopoulos, Pota ^b   Cameron, Lisa ^b   Durham, Steven ^b   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

Allergic rhinitis; Chemokines; Chronic sinusitis; Cytokines; Inflammation

Indexed keywords

CD4 ANTIGEN; CORTICOSTEROID; CYTOKINE; FLUTICASONE PROPIONATE; HISTAMINE; IMMUNOGLOBULIN E; LEUKOTRIENE; MOMETASONE FUROATE; PROSTANOID;

ALLERGIC RHINITIS; ARTICLE; CHRONIC SINUSITIS; CYTOKINE PRODUCTION; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; NOSE CONGESTION; PRIORITY JOURNAL; RHINORRHEA; SNEEZING; UPPER RESPIRATORY TRACT;

ANIMALS; CHRONIC DISEASE; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SINUSITIS;

EID: 0033964392     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(00)90068-x     Document Type: Article

References (166)

1. National Institute of Allergy and Infectious Diseases Task Force. Asthma and other allergic diseases. Washington (DC): US Department of Health, Education and Welfare; 1979. NIH Publication No.: 79-387.
2. Mygind N, Jacobi H. Structure and function of the upper airways. In: Kay AB, editor. Allergy and allergic diseases. 1st ed. London: Blackwell Science; 1997. p 1300-10.
3. Sanai A, Nagata H, Konno A. Extensive interstitial collagen deposition on the basement membrane zone in allergic nasal mucosa. Acta Otolaryngol 1999; 119:473-8.
4. Mygind N, Pederson M, Nielson MH. Morphology of the upper airway epithelium. In: Proctor DF, Anderson I, editors. The nose, upper airway physiology and the atmospheric environment. Amsterdam: Elsevier Biomedical Press; 1982. p 71-97.
5. Kaliner MA. Human respiratory secretions and host defense. Am Rev Respir Dis 1991;144:S52-66.
6. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol 1992;90:699-704.
7. Masuda S. Quantitative histochemistry of mucus-secreting cells in human nasal mucosa.
8. Igarashi Y, Scott TA, Hausfeld JH, Kaliner MA, White MV. Inflammatory cell infiltrates in human nasal mucosa [abstract 240], J Allergy Clin Immunol 1992;89:204.
9. Bentley AM, Jacobson MR, Cumberworth V, Barkans JR, Moqbel R, Schwartz LB, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89:877-83.
10. Igarashi Y, White M, Hausfeld J, Irani A, Schwartz L, Kaliner M. IgE-positive cells in nasal mucosa are mostly mast cells [abstract], FASEB J 1992;6:A2005.
11. Busattil A, More IAR, McSeveney D. A reappraisal of the ultrastructure of the human respiratory nasal mucosa. J Anat 1977;124:445-58.
12. Jahnke V. Electron microscopy of the normal nasal mucosa. Acta Otorhinolaryngol Belg 1978;32:48-55.
13. Wilson SJ, Howarth PH. Collagen phenotypes and subepithelial collagen band thickness in the allergic nasal mucosa [abstract]. Am J Resp Crit CareMed 1995;151:A563.
14. Kern EB. It is really sinusitis? Postgrad Med 1983;74:156-7, 160.
15. Cendan E, Jankowski R. Infections aigues naso-sinusiennes et pharyngees de l'enfant: ethiologie, physiopathologie, diagnostic, traitement. Rev Practicien 1994;44:1825-32.
16. McDonald DM. Neurogenic inflammation in the respiratory tract: clinical allergy and immunology. New York: Marcel Dekker; 1996. p 575-603.
17. Sommerhof CP, Caughey GH, Finkbeiner WE, Lazarus SC, Basbaum CB, Nadel JA. Mast cell chymase: a potent secretagogue for airway gland serous cells. J Immunol 1989;142:2450-6.
18. Svensson C, Anderson M, Greiff L, Alkner U, Persson CGA. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 1995;25:942-50.
19. Sanico AM, Atsuta S, Togias A. Leukocyte influx after capsaicin nasal challenge is a dose dependent phenomenon [abstract], J Allergy Clin Immunol 1996;97:A30.
20. Bradding P, Feather IH, Wilson S, Bardin P, Holgate ST, Howarth PH. Immunolocolisation of cytokines in the nasal mucosa of normal and perennial rhinitis subjects: the mast cell as a source of IL-4, IL-5 and IL-6 in human allergic inflammation. J Immunol 1993;151:3853-65.
21. Lozewicz S, Wang J, Duddle J, Thomas K, Chalstrey S, Reilly G, et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992;89:951-7.
22. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilon-RI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997;99:1492-9.
23. Ohkawara Y, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H, et al. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992;7:385-92.
24. Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI: a mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 1991;174:103-7.
25. Bradding P, Feather IH, Howarth PH, Mueller JA, Roberts K, Britten JP, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
26. Wilson SJ, Lau L, Howarth PH. Inflammatory mediators in naturally occurring rhinitis. Clin Exp Allergy 1998;28:220-7.
27. Tedeschi A, Milazzo N, Miadonna A. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein. Eur Respir J 1994;7:1445-51.
28. Erjefalt I, Persson CGA. Allergen, bradykinin, and capsaicin increase outward but not inward macromolecule permeability of guinea-pig tracheobronchial mucus. Clin Exp Allergy 1991;21:217-24.
29. Knani J, Campbell A, Enander I, Peterson CG, Michel FB, Bousquet J. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992;90:880-9.
30. Arnal JF, Didier A, Rami J, et al. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 1997;27:358-62.
31. Fischer A, Hoffman B. Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Am J Respir Crit Care Med 1996;154:209-16.
32. Martin U, Bryden K, Devoy M, Howarth P. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996; 97: 768-72.
33. Ferguson EA, Eccles R. Relationship between nasal nitric oxide concentration and nasal airway resistance. Rhinology 1997;35:120-3.
34. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy 1978;41:37-47.
35. Iliopoulos O, Proud D, Adkinson NF,Norman PS, Kagey-Sobotka A, Lichtenstein LM, et al. Relationshion between the early, and late, and rechallenge reaction to nasal challenge with antigen observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 1990;86:851-61.
36. Naclerio RM. Pathophysiology of perennial allergic rhinitis. Allergy 1997;52:7-13.
37. Okuda M, Watase T, Mezawa A, Liu CM. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988;60:537-40.
38. Juliusson S, Pipkorn U, Karlsson G, Enerback L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992;90:898-909.
39. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990;86:924-35.
40. Naclerio RM. Effects of antihistamines on inflammatory mediators. Ann Allergy 1993;71:292-5.
41. Varney VA, Jacobson MR, Sudderick RM, et al. Immuno histology of the nasal mucosa following allergen-induced rhinitis: identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992;146:170-6.
42. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal allergen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-9.
43. Pawankar RU, Okuda M, Hasegawa S, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059-67.
44. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony- stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
45. Holgate ST, Bradding BM, Sampson AP. Leukotriene antagonists andsynthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996; 98:1-13.
46. Volovitz B, Oscur SL, Berstein JM, Ogra PL. Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in rag-weed-sensitive children. J Allergy Clin Inimunol 1988;82:414-8.
47. Terada N, Kono A, Togawa K. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 1994;94:629-42.
48. Hisamatsu K., Ganbo T, Nakazawa T, Murakami T, Gleich G, Makiyama K, et al. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. J Allergy Clin Immunol 1990;86:52-63.
49. Thomas LL, Zheutlin LM, Gleich GJ. Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic protein. Immunology 1989;66:61-5.
50. Moy JN, Gleich GJ, Thomas LL. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein: effect on superoxide anion generation and lysosomal enzyme release. J Immumol 1990;145:2626-32.
51. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late-phase cutaneous reaction in man. J Immunol 1988;141:4158-64.
52. Oddera S, Silvestri M, Balbo A et al. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy 1996;51:100-7.
53. Wardlaw AJ, Dunette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1998;137:62-9.
54. Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992;148:2223-8.
55. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein L. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994;94:1303-9.
56. Ghaffar O, Laberge S, Jacobson MR, Lowhagen O, Rak S, Durham SR, et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997;17:17-24.
57. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
58. Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
59. Ying S, Durham SR, Jacobson MR, Rak S, Masuyama K, Lowhagen O, et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:200-6.
60. Sornasse T, Larenas PV, Davis KA, de Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med 1996;184:473-83.
61. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, et al. IL-4-induced adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1086-92.
62. Temann UA, Prasad B, Gallup MW, Basbaum C, Ho SB, Flavell RA, et al. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 1997;16:471-8.
63. Guo FH, Uetani K, Haque SJ, Williams BR, Dweik RA, Thunnissen FB, et al. Innterferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest 1997;100:829-38.
64. Munoz-Bellido FJ, Monteseirin FJ, Escribano MM, Delgado J, Velazquez E, Conde J. Effect of seasonal exposure to pollen on nonspecific interleukin-4, interleukin-5, and interferon-gamma in vitro release by peripheral blood mononuclear cells from subjects with pollinosis. Allergy 1998;53:420-5.
65. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989;73:1504-12.
66. Dewson G, Walsh GM, Wardlaw AJ. Expression of Bcl-2 and its homologues in human eosinophils: modulation by interleukin-5. Am J Respir Cell Mol Biol 1999;20:720-8.
67. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
68. Wardlaw AJ, Walsh GM, Symon FA. Adhesion interactions involved in eosinophil migration through vascular endothelium. Ann N Y Acad Sci 1996;796:124-37.
69. Del Prete G, Maggi E, Parronchi P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-8.
70. Punnonen J, Cocks BG, de Vries JE. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells: evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. J Immunol 1995;155:4248-54.
71. Wright ED, Frenkiel S, Al-Ghamdi K, Ghaffar O, Small P, Troutt T, Tavernier J, Hamid Q. IL-4, IL-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngol Head Neck Surg. 1998;118:490-5.
72. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996;4:313-9.
73. Shimoda K, Van deurson J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, et al. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996;380:627-30.
74. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwmura S, et al. Essential role of Stat6 in IL-4 signalling. Nature 1996;380:627-30.
75. Ghaffar O, Christodoulopoulos P, Lamkhioued B, Wright E, Nakamura Y, Frenkiel S, Hamid Q. In vivo expression of signal transducer and activator of transcription factor 6 (Stat6) in human allergic inflammation: effect of topical corticosteroids. Clin Exp Allergy 1999. In press.
76. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995;12:624-32.
77. Symon FA, McNulty CA, Wardlaw AJ. P- and L-selectin mediate binding of T cells to chronically inflamed human airway endothelium. Eur J Immunol 1999;29:1324-33.
78. Montefort S, Feather IH, Wilson SJ, Haskard DO, Lee TH, Holgate ST, et al. The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992;7:393-8.
79. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitement. J Allergy Clin Immunol 1994;94:427-38.
80. Lee BJ, Naclerio RM, Bochner BS, Taylor RM, Lim MC, Baroody FM. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol 1994;94:1006-16.
81. Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 1991;146:592-8.
82. Minshall E, Cameron L, Lavigne F, Leung DYM, Hamilos D, Rothenberg M, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
83. Christodoulopoulos P, Wright E, Frenkiel S, Luster A, Hamid Q. Monocyte chemotactic proteins in allergic-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol 1999;103:1036-44.
84. Schall TJ, Jongstra J, Dyer BJ, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988;141:1018-25.
85. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449-56.
86. Garcia-Zepeda EA, Combadiere C, Rothenberg ME, et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996;157):5613-26.
87. Kuna P, Alam R, Ruta U, Gorski P. RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am J Respir Crit Care Med 1998;157:873-9.
88. Rajakulasingam K, Hamid Q, O'Brien F, Schotman E, Jose PJ, Williams M, et al. RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia. Am J Respir Crit Care Med 1997;155:696-703.
89. Stellate C, Beck LA, Gorgone GA, et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids. J Immunol 1995;155:410-8.
90. Li L, Xia Y, Nguyen A, et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87.
91. Cruikshank WW, center DM, Nisar N, Natke B, Theodore AC, Kornfeld H. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biological function with CD4 expression. Proc Natl Acad Sci U S A 1994;91:5109-13.
92. Center DM, Kornfeld H, Cruikshank WW. Interleukin-16 and its function as a CD4 ligand. Immunol Today 1996;17:476-81.
93. Laberge S, Durham S, Ghaffar O, Rak S, Center DM, Jacobson M, et al. Expression of IL-16 in allergic-induced late phase nasal responses and relation to topical glucocorticosteroid treatment. J Allergy Clin Immunol 1997;100:569-74.
94. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
95. Harlin SL, Ansel DG, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;81:867-75.
96. Dolovich J, Ohtoshi T, Jordana M, Gauldie J. Nasal polyps: local inductive microenvironment in the pathogenesis of the inflammation. In: Mygind N, Pipkorn U, Dahl R, editors. Rhinitis and asthma. Copenhagen: Munksgaard; 1990. p 233-41.
97. Hamilos DL, Leung DYM, Wood R, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony stimulating factor and interleukin 3. J Allergy Clin Immunol 1993;92:39-48.
98. Hamilos DL, Leung DYM, Wood R, Meyers A, Stephens JK, Barkans J, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 1993;92:39-48.
99. Hamilos DL, Leung DYM, Wood R, Cunningham L, Bean DK, Yasruel Z, et al. Evidence for distinct cytokine expression in allergic versus non-allergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537-44.
100. Kamil A, Ghaffar O, Lavigne F, Taha R, Renzi P, Hamid Q. Comparison of inflammatory cell profile and Th2 cytokine expression in the ethmoid sinus, maxillary sinus, maxillary sinus, and turbinate of atopic subjects with chronic sinusitis. Otolaryngol Head Neck Surg 1998;118:804-9.
101. Al-Ghamdi K, Ghaffar O, Small P, Frenkiel S, Hamid Q. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and the effect of topical corticosteroid treatment. J Otolaryngol 1997;26:160-6.
102. Ghaffar O, Lavigne F, Kamil A, Renzi PM, Hamid QA. IL-6 expression in chronic sinusitis: co-localization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 1998;118:504-11.
103. Wright E, Frenkiel S, Ghaffar O, Al-Ghamdi K, Luster A, Miotto D, et al. Monocyte chemotactic protein expression in allergy and non-allergy-associated chronic sinusitis. J Otolaryngol 1998;27:281-7.
104. Wright ED, Christodoulopoulos P, Frenkiel S, Hamid Q. Expression of IL-12 (p40) and IL-12 (b2) receptors in allergic rhinitis and chrinic sinusitis. Clin Exp Allergy 1999;29:1320-5.
105. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995;2:665-75.
106. Hamilos DL, Leung DYM, Wood R, Bean DK, Song YL, Schotman E, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-a. Am Respir Cell Mol Biol 1996;15:443-50.
107. Cotran R, Kumar V, Robin S. Inflammation and repair. In: Cotran R, Kumar V, Robin S, editors. Robins pathologic basis of disease. Philadelphia: WB Saunders; 1989. p 39-87.
108. Bousquet J, Chanez P, Lacoste JY. Asthma: a disease remodeling the airways. Allergy 1992;47:3-11.
109. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, Wolley K, et al. Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. Am J Respir Cell Mol Biol 1995;13:639-47.
110. Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997;16:664-73.
111. Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994;93:864-9.
112. Minshall E, Leung DYM, Martin RJ, Song YL, Cameron L, Ernst P, et al. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997;17:326-33.
113. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
114. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991;174:745-8.
115. Minshall E, Chakir J, Laviolette M, Olivenstein R, Zhu Z, Elias JA, et al. Interleukin-11 mRNA expression is increased in severe asthma: localization to eosinophils [abstract], J Allergy Clin Immunol 1999;103:A222.
116. Rochester CL, Ackerman SJ, Zheng T, Elias JA. Eosinophil-fibroblast interactions: granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol 1996;156:4449-56.
117. Chakir J, Laviolette M, Boutet M, Laliberte R, Dube J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75:735-44.
118. Eidelman DH, Minshall E, Dandurand RJ, Schotman E, Song YL, Yasruel Z, et al. Evidence for major basic protein immunoreactivity and interleukin 5 gene activation during the late phase response in explanted airways. Am J Respir Cell Mol Biol 1996;15:582-9.
119. Wardlaw AJ, Walsh GM, Symon FA. Adhesion interactions involved in eosinophil migration through vascular endothelium. Ann N Y Acad Sci 1996;796:124-37.
120. Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992;89:1662-8.
121. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994;94:1183-8.
122. Lukacs NW, Stricter RM, Kunkel SL. Leukocyte infiltration in allergic airway inflammation. Am J Respir Cell Mol Biol 1995;13:1-6.
123. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine eotaxin activates guinea-pig eosinophils in vitro and causes their acumulation into the lung in vivo and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993;197:1167-72.
124. Shalit M, Sekhsaria S, Malech HL. Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL5 and other growth factors. Cell Immunol 1995;160:50-7.
125. Denburg JA, Telizyn S, Messner H, Lim B, Jamal N, Ackerman SJ, et al. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood 1985;66:312-8.
126. Gibson PG, Manning PJ, O'Byrne PM, Girgis-Gabardo A, Dolovich J, Denburg JA, et al. the inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils, and their progenitors. Clin Exp Allergy 1990;20:661-8.
127. Sehmi R, Howie K, Sutherland DR, Schragge W, O'Byrne PM, Denburg JA. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol 1996;15:645-55.
128. Robinson DS, North J, Zeibecoglou K, Ying S, Meng Q, Rankin S, et al. Eosinophil development and bone marrow and tissue eosinophils in atopic asthma. Int Arch Allergy Immunol 1999;118:98-100.
129. Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM, et al. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects: a novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 1997;100:2466-75.
130. Robinson DS, Ying S, Bentley AM, Meng Q, North J, Durham SR, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92:397-403.
131. Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet 1975;2:148-50.
132. Platts-Mills TA. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979;122:2218-25.
133. Diaz-Sanchez D, Dotson AR, Takenaka H, Saxon A. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest 1994;94:1417-25.
134. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol 1997;158:2406-13.
135. Iciek LA, Delphin SA, Stavnezer J. CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB: synergy with IL-4 induction. J Immunol 1997;158:4769-79.
136. Warren WD, Berton MT. Induction of germ-line gamma 1 and epsilon Ig gene expression in murine B cells: IL-4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J Immunol 1995;155:5637-46.
137. Lorenz M, Jung S, Radbruch A. Switch transcripts in immunoglobulin class switching. Science 1995;267:1825-8.
138. Davidsson A, Karlsson MG, Hellquist HB. Allergen-induced changes of B-cell phenotypes in patients with allergic rhinitis. Rhinology 1994;32:184-90.
139. Ghaffar O, Durham SR, Al-Ghamdi K, Wright E, Small P, Frenkiel S, et al. Expression of IgE heavy chain transcripts in the sinus mucosa of atopic and nonatopic patients with chronic sinusitis. Am J Respir Cell Mol Biol 1998;18:706-11
140. Gauchat JF, Lebman DA, Coffman RL, Gascan H, de Vries JE. Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production. J Exp Med 1990;172:463-73.
141. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, Waldschmidt TJ, et al. Mice deficient for the CD40 ligand. Immunity 1994;1:423-31.
142. Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27:2899-906.
143. Cameron LA, Durham SR, Jacobson MR, Masuyama K, Juliusson S, Gould HJ, et al. Expression of IL-4, Cε RNA, and le RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids. J Allergy Clin Immunol 1998;101:330-6.
144. Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995;25:737-43.
145. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993;48:476-90.
146. Orgel HA, Meltzer EO, Bierman CW, Bronsky E, Connell JT, Lieberman PL, et al. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12- month efficacy and safety study including nasal biopsy [abstract]. J Allergy Clin Immunol 1991;88:257.
147. Minshall E, Ghaffar O, Cameron L, O'Brien F, Quinn H, Rowe-Jones J, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998;118:648-54.
148. Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, et al. Influence of prolonged treatment with topical cortico steroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24:930-9.
149. Klementsson H, Svensson C, Anderson M, Venge P, Pipkorn U, Persson CGA. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:705-10.
150. Meltzer EO. Nasal cytological changes following pharmacological intervention. Allergy 1995;50(23 Suppl):15-20.
151. Okuda M, Sakaguchi K, Ohtsuka H. Intranasal beclomethasone: mode of action in nasal allergy. Ann Allergy 1983;50:116-20.
152. Pipkorn U. Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis. Allergy 1983;38:125-9.
153. Kondo H, Nachtigal D, Frenkiel S, Schotman E, Hamid Q. Effect of steroids on nasal inflammatory cells and cytokine profile. Laryngoscope 1999;109:91-7.
154. Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB, et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:192-9.
155. Rousset F, Robert J, Andary M, Bonnin JP, Souillet G, Chretien I, et al. Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991;87:58-69.
156. Sornasse T, Larenas PV, Davis KA, de Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med 1996;184:473-83.
157. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996;97:1356-65.
158. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in
159. McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PW. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 1990;86:521-31.
160. Ohashi Y, Nakai Y, Okamoto H, Ohno Y, Sakamoto H, Tanaka A, et al. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997;106:483-9.
161. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-gamma in immune regulation, I: IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988;140:4245-52.
162. Mayer M, Doenicke A, Nebauer AE, Rosenberger C, Lorenz W, Peter K. Pharmacodynamics and clinical adverse effects of mivacurium: the effect of oral premedication with II1/III2 antagonists. Anaesthesist 1993;42:592-6.
163. Kuna P, Alam R, Kuzminska B, Rozniecki J. The effect of preseasonal immunotherapy on the production of histamine- releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol 1989;83:816-24.
164. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 199;341:468-75.
165. Beasley R, Burgess C, Crane J, Pearce N, Roche W. Pathology of asthma and its clinical implications. J Allergy Clin Immun 1993;92:148-54.
166. Creticos, PS, Peters SP, Adkinson N, Naclerio RM, Hayes EC, Norman P, et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984;310:1626.